For instance, in NSCLC and HNSCC models, AXL expression sustains PI3K/AKT and MEK/ERK signaling and thus mediates resistance to the EGFR inhibition [24, 57]. The gene discussed is AXL; the disease is head and neck squamous cell carcinoma.